OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 116 filers reported holding OCULAR THERAPEUTIX INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,650 | -57.9% | 22,500 | -30.8% | 0.01% | -57.9% |
| Q2 2023 | $167,700 | -84.7% | 32,500 | -84.3% | 0.02% | -86.0% |
| Q1 2023 | $1,094,178 | +43.8% | 207,624 | -23.3% | 0.14% | +33.3% |
| Q4 2022 | $760,645 | -49.6% | 270,692 | -25.6% | 0.10% | -50.2% |
| Q3 2022 | $1,510,000 | +183.3% | 363,844 | +174.3% | 0.20% | +225.4% |
| Q2 2022 | $533,000 | -13.2% | 132,654 | +80.0% | 0.06% | -25.0% |
| Q2 2020 | $614,000 | +314.9% | 73,678 | +145.6% | 0.08% | +250.0% |
| Q1 2020 | $148,000 | -16.9% | 30,000 | -33.3% | 0.02% | +33.3% |
| Q4 2019 | $178,000 | – | 45,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |